InsidersTradesSigma
Explore the detailed record of transactions filed by Shmerling James E., 董事. Officer active across 1 company, notably Biostage, Inc.. Cumulatively, 1 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €96k. History available since 12 May 2022. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
James E. Shmerling serves as a Board Member at Biostage, Inc. With significant experience in the industry, he contributes to the governance of the company and strategic decision-making. His role as a board member involves overseeing operations and ensuring compliance with applicable regulations. James E. Shmerling is committed to promoting shareholder interests and supporting Biostage, Inc.'s mission in the biotechnology field.